Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Mereo BioPharma Group plc | Chief Financial Officer | American Depositary Shares representing Ordinary Shares | 89.3K | $377K | $4.22 | Sep 13, 2024 | Direct |
Mereo BioPharma Group plc | Chief Financial Officer | Share Options (Right to buy) | 245K | $247K | $1.01 | Jan 25, 2024 | Direct |
Mereo BioPharma Group plc | Chief Financial Officer | Performance Based Restricted Stock Unit | 0 | Sep 11, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MREO | Mereo BioPharma Group plc | Sep 12, 2024 | 2 | -$122K | 4 | Sep 16, 2024 | Chief Financial Officer |
MREO | Mereo BioPharma Group plc | Sep 11, 2024 | 2 | $0 | 4 | Sep 13, 2024 | Chief Financial Officer |
MREO | Mereo BioPharma Group plc | Jun 25, 2024 | 2 | -$148K | 4 | Jun 27, 2024 | Chief Financial Officer |
MREO | Mereo BioPharma Group plc | Jun 21, 2024 | 2 | $0 | 4 | Jun 25, 2024 | Chief Financial Officer |
MREO | Mereo BioPharma Group plc | Jan 25, 2024 | 1 | $0 | 4 | Jan 26, 2024 | Chief Financial Officer |
MREO | Mereo Biopharma Group plc | Jan 1, 2024 | 0 | $0 | 3 | Jan 2, 2024 | Chief Financial Officer |